Skip to main content
. Author manuscript; available in PMC: 2023 Aug 8.
Published in final edited form as: Neuroepidemiology. 2022 Aug 8;56(5):373–379. doi: 10.1159/000526278

Table 2.

Age-Stratified ET and ET-Plus Classifications of Probands, First-degree and Second-degree Relatives

Probands (n=84) 1st-degree Relatives (n=182) 2nd-degree Relatives (n=48)
All ages
 ET 21 (27.3) 24 (13.6) 12 (25.0)
 ET-Plus 56 (72.7) 66 (37.5) 9 (18.8)
 Normal 0 (00.0) 86 (48.9) 27 (56.3)
 Not classifieda 7 6 0
pb 0.001 0.001 0.001
0–40 yrs
 ET 1 (100.0) 2 (10.0) 10 (38.5)
 ET-Plus 0 (00.0) 3 (15.0) 2 (07.7)
 Normal 0 (00.0) 15 (75.0) 14 (53.8)
 Not classifieda 0 0 0
41–50 yrs.
 ET 1 (33.3) 8 (27.6) 0 (00.0)
 ET-Plus 2 (66.7) 5 (17.2) 0 (00.0)
 Normal 0 (00.0) 16 (55.2) 7 (100.0)
 Not classifieda 0 0 0
51–60 yrs.
 ET 5 (45.5) 7 (17.1) 1 (14.3)
 ET-Plus 6 (54.5) 9 (22.0) 2 (28.6)
 Normal 0 (00.0) 25 (61.0) 4 (57.1)
 Not classifieda 1 0 0
61–70 yrs.
 ET 10 (31.3) 5 (11.1) 1 (16.7)
 ET-Plus 22 (68.8) 23 (51.1) 4 (66.7)
 Normal 0 (00.0) 17 (37.8) 1 (16.7)
 Not classifieda 1 1 0
71+ yrs.
 ET 4 (13.3) 2 (04.9) 0 (00.0)
 ET-Plus 26 (86.7) 26 (63.4) 1 (50.0)
 Normal 0 (00.0) 13 (31.7) 1 (50.0)
 Not classifieda 5 5 0
a

Enrollees who met criteria for ET, but cannot be classified regarding ET-plus due to missing data. These cases are not included in calculation of percentages.

b

Chi-square tests comparing ET, ET-plus, and normal frequencies within group. Bolded p values are significant at p < 0.05.

Values are frequencies (column percentages).